|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Translate Bio, Inc. (165173-OLD) |
|
|
$37.36 0.00 (0.00%) as of 4:30 Mon 9/13
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
74,320,000 |
Market
Cap: |
2.78(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$37.36 - $37.36 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Klarman Seth A |
10% Owner |
|
2021-09-14 |
4/A |
D |
$38.00 |
$685,681,082 |
I/I |
(18,044,239) |
0 |
|
- |
|
Formela Jean Francois |
Director |
|
2021-09-14 |
4 |
AS |
$38.00 |
$78,092,394 |
I/I |
(2,055,063) |
0 |
|
- |
|
Sanofi-Aventis |
10% Owner |
|
2021-09-14 |
4 |
B |
$38.00 |
$2,147,483,647 |
D/D |
71,983,597 |
75,668,031 |
2.45 |
- |
|
Burgess Paul D. |
Chief Operating Officer, CLOSe |
|
2021-09-14 |
4 |
S |
$38.00 |
$2,729,654 |
D/D |
(71,833) |
0 |
|
- |
|
Renaud Ronald C Jr |
Chief Executive Officer |
|
2021-09-14 |
4 |
S |
$38.00 |
$17,131,236 |
I/I |
(450,822) |
0 |
|
- |
|
Renaud Ronald C Jr |
Chief Executive Officer |
|
2021-09-14 |
4 |
S |
$38.00 |
$19,122,778 |
D/D |
(503,231) |
0 |
|
- |
|
Hughes Owen |
Director |
|
2021-09-14 |
4 |
S |
$38.00 |
$1,134,680 |
D/D |
(29,860) |
0 |
|
- |
|
Renaud Ronald C Jr |
Chief Executive Officer |
|
2021-04-07 |
4/A |
OE |
$7.39 |
$66,702 |
D/D |
9,026 |
503,231 |
|
- |
|
Renaud Ronald C Jr |
Chief Executive Officer |
|
2021-04-07 |
4 |
OE |
$7.39 |
$66,702 |
D/D |
9,026 |
503,321 |
|
- |
|
Renaud Ronald C Jr |
Chief Executive Officer, Pres. |
|
2021-01-14 |
4 |
OE |
$7.39 |
$41,673 |
D/D |
5,639 |
494,205 |
|
- |
|
Formela Jean Francois |
Director |
|
2020-12-22 |
4 |
AS |
$25.04 |
$2,069,870 |
I/I |
(82,565) |
43,940 |
|
- |
|
Formela Jean Francois |
Director |
|
2020-12-21 |
4 |
AS |
$25.50 |
$1,441,928 |
I/I |
(56,536) |
126,505 |
|
- |
|
Renaud Ronald C Jr |
Chief Executive Officer, Pres. |
|
2020-11-16 |
4 |
OE |
$7.39 |
$391,725 |
D/D |
53,007 |
488,566 |
|
- |
|
Formela Jean Francois |
Director |
|
2020-08-27 |
4 |
S |
$14.38 |
$145,217 |
I/I |
(10,097) |
3,833,122 |
|
- |
|
Formela Jean Francois |
Director |
|
2020-08-26 |
4 |
S |
$14.80 |
$656,746 |
I/I |
(44,381) |
3,843,219 |
|
- |
|
Formela Jean Francois |
Director |
|
2020-08-25 |
4 |
S |
$15.00 |
$516,160 |
I/I |
(34,410) |
3,887,600 |
|
- |
|
Takeda Pharmaceutical Co Ltd |
10% Owner |
|
2020-06-30 |
4 |
S |
$20.68 |
$141,140,835 |
D/D |
(6,824,992) |
0 |
|
- |
|
Klarman Seth A |
10% Owner |
|
2020-06-26 |
4 |
B |
$22.00 |
$11,000,000 |
I/I |
500,000 |
18,044,239 |
1.5 |
- |
|
Takeda Pharmaceutical Co Ltd |
10% Owner |
|
2020-06-03 |
4 |
S |
$19.75 |
$791,699 |
D/D |
(40,086) |
6,824,992 |
|
- |
|
Takeda Pharmaceutical Co Ltd |
10% Owner |
|
2020-06-02 |
4 |
S |
$19.75 |
$2,082,903 |
D/D |
(105,395) |
6,865,078 |
|
- |
|
Takeda Pharmaceutical Co Ltd |
10% Owner |
|
2020-06-01 |
4 |
S |
$19.85 |
$2,154,121 |
D/D |
(108,472) |
6,970,473 |
|
- |
|
Klarman Seth A |
10% Owner |
|
2019-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,544,239 |
|
- |
|
Takeda Pharmaceutical Co Ltd |
10% Owner |
|
2019-01-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,078,945 |
|
- |
|
Gallagher Brian M. Jr. |
Director |
|
2018-07-02 |
4 |
B |
$13.00 |
$3,499,990 |
I/I |
269,230 |
3,697,912 |
2.1 |
- |
|
Gallagher Brian M. Jr. |
Director |
|
2018-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,428,682 |
3,428,682 |
|
- |
|
35 Records found
|
|
Page 1 of 2 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|